E11.3492 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, left eye

Name of the Condition

• Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, left eye

Summary

Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, left eye, is a condition where chronic high blood sugar levels cause significant damage to the retinal blood vessels in the left eye, leading to advanced retinal changes without new blood vessel growth (proliferation) and no fluid accumulation in the macula. This stage is characterized by widespread retinal ischemia, intraretinal microvascular abnormalities, and venous beading in the left eye. While vision may not be severely impaired at this stage, the risk of progression to proliferative diabetic retinopathy or vision-threatening complications in the left eye is high if not managed appropriately.

Causes

High blood sugar levels over time damage the small blood vessels in the retina of the left eye, leading to severe nonproliferative diabetic retinopathy without macular edema. Prolonged hyperglycemia in type 2 diabetes triggers vascular changes, including capillary closure and retinal ischemia in the left eye. Metabolic factors associated with diabetes, such as advanced glycation end products and oxidative stress, contribute to this ocular complication. Insulin resistance or insufficient insulin production in type 2 diabetes sustains hyperglycemia, accelerating retinal damage.

Risk Factors

• Poorly controlled blood glucose levels.
• Long duration of diabetes.
• Hypertension and dyslipidemia.
• Smoking.
• Obesity and sedentary lifestyle.
• Family history of diabetic retinopathy.

Symptoms

• Blurred or distorted vision in the left eye.
• Floaters or spots in the visual field.
• Difficulty seeing in low light.
• Reduced color perception.
• Asymptomatic in early stages (often detected via screening).

Diagnosis

Diagnosis involves a comprehensive eye examination, including dilated retinal imaging (e.g., fundus photography, optical coherence tomography) to assess retinal changes. Fluorescein angiography may be used to evaluate blood flow and identify ischemia. Blood tests to monitor glycemic control (e.g., HbA1c) and systemic factors (e.g., lipid profile) support diagnosis. Clinical correlation with diabetes history is essential.

Treatment Options

• Intensive glycemic control to slow retinal progression.
• Blood pressure and lipid management.
• Regular eye screenings to monitor for advancement.
• Laser photocoagulation or anti-VEGF therapy if progression occurs.
• Lifestyle modifications (diet, exercise) to improve metabolic health.

Prognosis and Follow-Up

Prognosis depends on timely management; severe nonproliferative diabetic retinopathy without macular edema may stabilize with strict glycemic control but carries a risk of progression to proliferative retinopathy or macular edema. Follow-up every 3–6 months is recommended, with more frequent visits if changes occur. Early intervention reduces vision loss risk.

Complications

• Progression to proliferative diabetic retinopathy (new blood vessel growth).
• Macular edema (fluid accumulation in the macula).
• Retinal detachment.
• Vision loss or blindness if untreated.

Lifestyle & Prevention

• Maintain target blood glucose levels through diet, exercise, and medication.
• Control blood pressure and cholesterol.
• Avoid smoking and limit alcohol.
• Regular physical activity and weight management.
• Annual dilated eye exams for early detection.

When to Seek Professional Help

Seek immediate care if you experience sudden vision changes, increased floaters, or eye pain. Routine follow-ups with an ophthalmologist are critical for monitoring retinal status and adjusting treatment.

Tips for Medical Coders

Document the eye laterality (left eye) and confirm the absence of macular edema. Ensure clinical notes specify "severe nonproliferative diabetic retinopathy" without proliferative changes or macular involvement. Code E11.3492 requires clear documentation of the left eye and the nonproliferative, non-edematous nature of the retinopathy.